Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2015, Article ID 760429, 4 pages
http://dx.doi.org/10.1155/2015/760429
Case Report

Serous Tubal Intraepithelial Carcinoma: An Incidental Finding at the Time of Prophylactic Bilateral Salpingo-Oophorectomy

1Department of Obstetrics and Gynecology, University of Virginia Health System, Charlottesville, VA, USA
2Thornton Gynecologic Oncology Division, Department of Obstetrics and Gynecology, University of Virginia Health System, Charlottesville, VA, USA
3Department of Pathology, University of Virginia Health System, Charlottesville, VA, USA
4Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, University of Virginia Health System, Charlottesville, VA, USA

Received 23 November 2014; Revised 7 February 2015; Accepted 7 February 2015

Academic Editor: Yoshio Yoshida

Copyright © 2015 Monique Hiersoux Vaughan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Finch, P. Shaw, B. Rosen, J. Murphy, S. A. Narod, and T. J. Colgan, “Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers,” Gynecologic Oncology, vol. 100, no. 1, pp. 58–64, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. S. L. Wethington, K. J. Park, R. A. Soslow et al., “Clinical outcome of isolated Serous tubal intraepithelial carcinomas (STIC),” International Journal of Gynecological Cancer, vol. 23, no. 9, pp. 1603–1611, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Manchanda, A. Abdelraheim, M. Johnson et al., “Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status,” BJOG: An International Journal of Obstetrics and Gynaecology, vol. 118, no. 7, pp. 814–824, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. T. Rabban, K. Garg, B. Crawford, L.-M. Chen, and C. J. Zaloudek, “Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery,” American Journal of Surgical Pathology, vol. 38, no. 6, pp. 729–742, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Ishikawa, T. Kiyokawa, E. Utsuno, K. Matsushita, F. Nomura, and M. Shozu, “Serous tubal intraepithelial carcinoma in a Japanese woman with a deleterious BRCA1 mutation,” Japanese Journal of Clinical Oncology, vol. 44, no. 6, pp. 597–601, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Nasser, R. Arsenic, P. Lohneis, P. Kosian, and J. Sehouli, “A case of primary peritoneal carcinoma: evidence for a precursor in the fallopian tube,” Anticancer Research, vol. 34, no. 1, pp. 407–412, 2014. View at Google Scholar · View at Scopus
  7. M. J. Callahan, C. P. Crum, F. Medeiros et al., “Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction,” Journal of Clinical Oncology, vol. 25, no. 25, pp. 3985–3990, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. D. W. Kindelberger, Y. Lee, A. Miron et al., “Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship,” The American Journal of Surgical Pathology, vol. 31, no. 2, pp. 161–169, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. S. C. Modesitt, “What is new in gynecologic oncology? Thought-provoking articles from the past year,” Obstetrics and Gynecology, vol. 121, no. 4, pp. 872–873, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. C. P. Crum, F. D. McKeon, and W. Xian, “The oviduct and ovarian cancer: causality, clinical implications, and ‘targeted prevention’,” Clinical Obstetrics and Gynecology, vol. 55, no. 1, pp. 24–35, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Vang, I.-M. Shih, and R. J. Kurman, “Fallopian tube precursors of ovarian low- and high-grade serous neoplasms,” Histopathology, vol. 62, no. 1, pp. 44–58, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Chene, A. Cayre, I. Raoelfils, N. Lagarde, J. Dauplat, and F. Penault-Llorca, “Morphological and immunohistochemical pattern of tubo-ovarian dysplasia and serous tubal intraepithelial carcinoma,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 183, pp. 89–95, 2014. View at Google Scholar
  13. F. Medeiros, M. G. Muto, Y. Lee et al., “The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome,” The American Journal of Surgical Pathology, vol. 30, no. 2, pp. 230–236, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. National Comprehensive Cancer Network, Genetic/Familial High-Risk Assessment: Breast and Ovarian (Version 1.2014), 2014, http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf.
  15. American College of Obstetricians and Gynecologists, ACOG Committee on Practice Bulletins, ACOG Committee on Genetics, and Society of Gynecologic Oncologists, “ACOG Practice Bulletin No. 103: hereditary breast and ovarian cancer syndrome,” Obstetrics & Gynecology, vol. 113, no. 4, pp. 957–966, 2009. View at Google Scholar